Curated Information
Javascript is not enabled on this browser. This site will not work properly without Javascript.
PhosphoSitePlus Homepage PhosphoSitePlus® v6.7.5
Powered by Cell Signaling Technology
Home > Curated Information Page > PubMed Id: 23273980
Chocarro-Calvo A, et al. (2013) Glucose-induced β-catenin acetylation enhances Wnt signaling in cancer. Mol Cell 49, 474-86 23273980
This page summarizes selected information from the record referenced above and curated into PhosphoSitePlus®, a comprehensive online resource for the study of protein post-translational modifications (NAR, 2015, 43:D512-20). To learn more about the scope of PhosphoSitePlus®, click here.
Click on the protein name to open the protein page, and on the RSD number to open the site page.
Download

K354-ac - CTNNB1 (human)
Modsite: LSVCSsNkPAIVEAG SwissProt Entrez-Gene
Orthologous residues
CTNNB1 (human): K354‑ac, CTNNB1 (mouse): K354‑ac, CTNNB1 (rat): K354‑ac, CTNNB1 (rabbit): K354‑ac
Characterization
Methods used to characterize site in vivo immunoprecipitation, modification-specific antibody, mutation of modification site, western blotting
Disease tissue studied:  breast cancer, colorectal cancer, colorectal carcinoma, ovarian cancer, pancreatic cancer, pancreatic carcinoma
Relevant cell lines - cell types - tissues:  Aspc1 (pancreatic), HT-29 (intestinal), MDA-MB-231 (breast cell), OVCAR3 (ovarian), STC-1 (endocrine)
Cellular systems studied:  cell lines
Species studied:  human, mouse
Upstream Regulation
Potential in vivo enzymes for site: 
Type Enzyme Evidence Notes
ACETYLTRANSFERASE p300 (human) co-immunoprecipitation, transfection of wild-type enzyme, pharmacological inhibitor of upstream enzyme
DEACETYLASE SIRT1 (human) co-immunoprecipitation, pharmacological activator of upstream enzyme, siRNA inhibition of enzyme, pharmacological inhibitor of upstream enzyme
Treatments, proteins and their effect on site modification: 
Treatments Referenced Treatments Manipulated Protein Referenced Protein Effect Notes
resveratrol decrease
nicotinamide increase
lithium, glucose increase
C646 glucose, lithium inhibit treatment-induced increase
resveratrol glucose, lithium inhibit treatment-induced increase
nicotinamide glucose, lithium augment treatment-induced increase
Downstream Regulation
Effect of modification (function):  intracellular localization, molecular association, regulation
Effect of modification (process):  transcription, induced
Modification regulates interactions with: 
Interacting molecule Interacting domains Effect Consequences (function) Consequences (process) Detection assays
LEF-1 (human) Induces co-immunoprecipitation, pull-down assay